Skip to Content

Pfizer - Celebrex, Bextra

Pfizer, Inc. - Celebrex, Bextra

This pharmaceutical company allegedly used deceptive advertising regarding the efficacy of Celebrex and Bextra in violation of the Tennessee Consumer Protection Act. This was a multistate case. The State of Tennessee received $990,911.00 of the total $60 million paid by Pfizer in the settlement.

Press Release

State Court Filings in Pfizer - Celebrex, Bextra

This list includes only significant filings and is not intended to be a complete record of the matter.